Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Delila Gasi Tandefelt

Forskare

Delila Gasi Tandefelt
Forskare
Molecular medicine, prostate cancer, circulating tumour DNA
Akademisk grad: Doktor,
delila.gasi.tandefelt@gu.se
031-786 6647
0766-186647

Rumsnummer: 4522B
Postadress: Box 425, 41390 Göteborg
Besöksadress: Medicinaregatan 1F , 41390 Göteborg
Arbetsuppgifter: Sahlgrenska Academy Research Fellow


Avd för urologi vid Institutionen för kliniska vetenskaper (Mer information)
Sahlgrenska Universitetssjukhuset
413 45 Göteborg
0313424145
Besöksadress: Bruna stråket 11b V 2 SU/Sahlgrenska , 413 45 Göteborg

Utvalda publikationer

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.
V Conteduca, D Wetterskog, M T A Sharabiani, E Grande, M P Fernandez-Perez et al.
Annals of oncology : official journal of the European Society for Medical Oncology, 2017

Plasma AR and abiraterone-resistant prostate cancer.
Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca, Anuradha Jayaram, Nicola Casiraghi et al.
Science translational medicine, 2015

Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration.
Jean Sebastien Frenel, Suzanne Carreira, Jane Goodall, Desam Roda, Raquel Perez-Lopez et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 2015

ETS fusion genes in prostate cancer.
Delila Gasi Tandefelt, Joost Boormans, Karin Hermans, Jan Trapman
Endocrine-related cancer, 2014

Overexpression of full-length ETV1 transcripts in clinical prostate cancer due to gene translocation.
Delila Gasi, Hetty A van der Korput, Hannie C Douben, Annelies de Klein, Corrina M de Ridder et al.
PloS one, 2011

Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer.
Karin G Hermans, Joost L Boormans, Delila Gasi, Geert J H L van Leenders, Guido Jenster et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 2009

Senaste publikationer

Circulating cell-free DNA: Translating prostate cancer genomics into clinical care.
Delila Gasi Tandefelt, Johann de Bono
Molecular aspects of medicine, Artikel i vetenskaplig tidskrift 2020
Artikel i vetenskaplig tidskrift

Identification of single nucleotide variants using position-specific error estimation in deep sequencing data.
Dimitrios Kleftogiannis, Marco Punta, Anuradha Jayaram, Shahneen Sandhu, Stephen Q Wong et al.
BMC medical genomics, Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.
V Conteduca, D Wetterskog, M T A Sharabiani, E Grande, M P Fernandez-Perez et al.
Annals of oncology : official journal of the European Society for Medical Oncology, Artikel i vetenskaplig tidskrift 2017
Artikel i vetenskaplig tidskrift

Plasma AR and abiraterone-resistant prostate cancer.
Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca, Anuradha Jayaram, Nicola Casiraghi et al.
Science translational medicine, Artikel i vetenskaplig tidskrift 2015
Artikel i vetenskaplig tidskrift

Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration.
Jean Sebastien Frenel, Suzanne Carreira, Jane Goodall, Desam Roda, Raquel Perez-Lopez et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, Artikel i vetenskaplig tidskrift 2015
Artikel i vetenskaplig tidskrift

ETS fusion genes in prostate cancer.
Delila Gasi Tandefelt, Joost Boormans, Karin Hermans, Jan Trapman
Endocrine-related cancer, Forskningsöversiktsartikel 2014
Forskningsöversiktsartikel

A 36-gene signature predicts clinical progression in a subgroup of ERG-positive prostate cancers.
Delila Gasi Tandefelt, Joost L Boormans, Hetty A van der Korput, Guido W Jenster, Jan Trapman
European urology, Artikel i vetenskaplig tidskrift 2013
Artikel i vetenskaplig tidskrift

Androgen regulation of ETS gene fusion transcripts in prostate cancer.
Delila Gasi, Jan Trapman
Methods in molecular biology (Clifton, N.J.), Kapitel i bok 2011
Kapitel i bok

Overexpression of full-length ETV1 transcripts in clinical prostate cancer due to gene translocation.
Delila Gasi, Hetty A van der Korput, Hannie C Douben, Annelies de Klein, Corrina M de Ridder et al.
PloS one, Artikel i vetenskaplig tidskrift 2011
Artikel i vetenskaplig tidskrift

Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer.
Karin G Hermans, Joost L Boormans, Delila Gasi, Geert J H L van Leenders, Guido Jenster et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, Artikel i vetenskaplig tidskrift 2009
Artikel i vetenskaplig tidskrift

Utvalda publikationer

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.
V Conteduca, D Wetterskog, M T A Sharabiani, E Grande, M P Fernandez-Perez et al.
Annals of oncology : official journal of the European Society for Medical Oncology, 2017

Plasma AR and abiraterone-resistant prostate cancer.
Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca, Anuradha Jayaram, Nicola Casiraghi et al.
Science translational medicine, 2015

Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration.
Jean Sebastien Frenel, Suzanne Carreira, Jane Goodall, Desam Roda, Raquel Perez-Lopez et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 2015

ETS fusion genes in prostate cancer.
Delila Gasi Tandefelt, Joost Boormans, Karin Hermans, Jan Trapman
Endocrine-related cancer, 2014

Overexpression of full-length ETV1 transcripts in clinical prostate cancer due to gene translocation.
Delila Gasi, Hetty A van der Korput, Hannie C Douben, Annelies de Klein, Corrina M de Ridder et al.
PloS one, 2011

Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer.
Karin G Hermans, Joost L Boormans, Delila Gasi, Geert J H L van Leenders, Guido Jenster et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 2009

Visar 1 - 10 av 10

2020

Circulating cell-free DNA: Translating prostate cancer genomics into clinical care.
Delila Gasi Tandefelt, Johann de Bono
Molecular aspects of medicine, Artikel i vetenskaplig tidskrift 2020
Artikel i vetenskaplig tidskrift

2019

Identification of single nucleotide variants using position-specific error estimation in deep sequencing data.
Dimitrios Kleftogiannis, Marco Punta, Anuradha Jayaram, Shahneen Sandhu, Stephen Q Wong et al.
BMC medical genomics, Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

2017

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.
V Conteduca, D Wetterskog, M T A Sharabiani, E Grande, M P Fernandez-Perez et al.
Annals of oncology : official journal of the European Society for Medical Oncology, Artikel i vetenskaplig tidskrift 2017
Artikel i vetenskaplig tidskrift

2015

Plasma AR and abiraterone-resistant prostate cancer.
Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca, Anuradha Jayaram, Nicola Casiraghi et al.
Science translational medicine, Artikel i vetenskaplig tidskrift 2015
Artikel i vetenskaplig tidskrift

Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration.
Jean Sebastien Frenel, Suzanne Carreira, Jane Goodall, Desam Roda, Raquel Perez-Lopez et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, Artikel i vetenskaplig tidskrift 2015
Artikel i vetenskaplig tidskrift

2014

ETS fusion genes in prostate cancer.
Delila Gasi Tandefelt, Joost Boormans, Karin Hermans, Jan Trapman
Endocrine-related cancer, Forskningsöversiktsartikel 2014
Forskningsöversiktsartikel

2013

A 36-gene signature predicts clinical progression in a subgroup of ERG-positive prostate cancers.
Delila Gasi Tandefelt, Joost L Boormans, Hetty A van der Korput, Guido W Jenster, Jan Trapman
European urology, Artikel i vetenskaplig tidskrift 2013
Artikel i vetenskaplig tidskrift

2011

Androgen regulation of ETS gene fusion transcripts in prostate cancer.
Delila Gasi, Jan Trapman
Methods in molecular biology (Clifton, N.J.), Kapitel i bok 2011
Kapitel i bok

Overexpression of full-length ETV1 transcripts in clinical prostate cancer due to gene translocation.
Delila Gasi, Hetty A van der Korput, Hannie C Douben, Annelies de Klein, Corrina M de Ridder et al.
PloS one, Artikel i vetenskaplig tidskrift 2011
Artikel i vetenskaplig tidskrift

2009

Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer.
Karin G Hermans, Joost L Boormans, Delila Gasi, Geert J H L van Leenders, Guido Jenster et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, Artikel i vetenskaplig tidskrift 2009
Artikel i vetenskaplig tidskrift

Visar 1 - 10 av 10

Sidansvarig: Katarina Olinder Eriksson|Sidan uppdaterades: 2013-07-17
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?

Denna text är utskriven från följande webbsida:
http://urology.gu.se/forskning-och-personal/personal/?tipFriend=true&tipUrl=http%3A%2F%2Furology.gu.se%2Fforskning-och-personal%2Fpersonal%2F%3Fprint%3Dtrue%26userId%3Dxtandd&userId=xtandd
Utskriftsdatum: 2020-03-28